Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
This text is for informational functions solely and isn't an alternative choice to skilled medical recommendation, prognosis or therapy. Contact a certified medical...
Kathleen A. Dorritie, MD, hematologist/medical oncologist, the College of Pittsburgh Medical Middle’s Hillman Most cancers Middle; assistant professor of medication, Division of Oncology,...
